<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BCRX
BioCryst
$
()


  • BioCryst announces ORLADEYO approval in Peru

    7/9/2024 - 07:03am
  • BioCryst reports inducement grants under Nasdaq listing rule

    7/2/2024 - 07:05am
  • BioCryst reports inducement grants under Nasdaq listing rule

    6/4/2024 - 07:13am
  • BioCryst presents real-world evidence showing reductions in attack rates in HAE

    6/2/2024 - 07:44am
  • Biotech Alert: Searches spiking for these stocks today

    5/17/2024 - 10:01am
  • BioCryst's ORLADEYO approved in Mexico

    5/13/2024 - 07:14am
  • Biotech Alert: Searches spiking for these stocks today

    5/9/2024 - 11:06am
  • BioCryst presents real-world evidence on use of ORLADEYO

    5/9/2024 - 08:15am
  • Biotech Alert: Searches spiking for these stocks today

    5/8/2024 - 11:11am
  • BioCryst price target raised by $1 at JMP Securities, here's why

    5/7/2024 - 06:53am
  • What You Missed On Wall Street On Monday

    5/6/2024 - 16:27pm
  • What You Missed On Wall Street This Morning

    5/6/2024 - 12:03pm
  • BioCryst sees 2024 ORLADEYO revenue $390M-$400M

    5/6/2024 - 07:14am
  • BioCryst expects total cash at end of 2024 to be above $300M

    5/6/2024 - 07:12am
  • BioCryst to advance avoralstat into DME clinical trial in 2025

    5/6/2024 - 07:11am
dynamic_feed Breaking News